Retraction: Designing of SiO2 mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression

doi:10.3389/fcell.2024.1540228

RETRACTION article

Front. Cell Dev. Biol. , 13 December 2024

Sec. Molecular and Cellular Pathology

Volume 12 - 2024 | https://doi.org/10.3389/fcell.2024.1540228

This article is part of the Research Topic Advance Utilization of Biodegradable Polymers in Drug Delivery View all 7 articles

Retraction: Designing of SiO₂ mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression

This article is a retraction of:

RETRACTED: Designing of SiO2 mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression
1. Read original article

Frontiers Editorial Office*

A Retraction of the Original Research Article
Designing of SiO₂ mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression

by Mehmood Y, Shahid H, Barkat K, Ibraheem M, Riaz H, Badshah SF, Chopra H, Sharma R, Nepovimova E, Kuca K, Valis M and Emran TB (2023). Front. Cell Dev. Biol. 10:1026477. doi: 10.3389/fcell.2022.1026477

The journal retracts the 6 January, 2023 article cited above.

Following publication, concerns were raised regarding the integrity of the images in this article. An investigation was conducted in accordance with Frontiers’ policies.

It was found that the concerns were valid and that the article does not meet the standards of editorial and scientific soundness for Frontiers in Cell and Developmental Biology; therefore, the article has been retracted.

The retraction was approved by the Chief Editors for Frontiers in Cell and Developmental Biology and the Chief Executive Editor of Frontiers. The authors do not approve of the retraction.

Citation: Frontiers Editorial Office (2024) Retraction: Designing of SiO₂ mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression. Front. Cell Dev. Biol. 12:1540228. doi: 10.3389/fcell.2024.1540228

Received: 05 December 2024; Accepted: 06 December 2024;
Published: 13 December 2024.

Approved by:

Ramani Ramchandran, Medical College of Wisconsin, United States

Copyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Retraction: Designing of SiO₂ mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro-inflammatory interferon and interleukin mRNA expression

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good